Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionProbity Advisors, Inc.
Latest Disclosed Ownership2,961 shares
Latest Disclosed Value $ 304,006
Probity Advisors, Inc. reports 0.30% decrease in ownership of ABL / Abbott Laboratories

On April 28, 2026 - Probity Advisors, Inc. filed a 13F-HR form disclosing ownership of 2,961 shares of Abbott Laboratories (DE:ABL) valued at $262,996 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 2,970 shares of Abbott Laboratories. This represents a change in shares of -0.30% during the quarter. The current value of the position is $222,726 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 2,961 -9 -0.30 304 -18.28 0.0482
2026-01-27 2025-12-31 13F ABBOTT LABS COM 002824100 2,970 -81 -2.65 372 -8.82 0.0596
2025-10-30 2025-09-30 13F ABBOTT LABS COM 002824100 3,051 -49 -1.58 409 -3.09 0.0662
2025-07-30 2025-06-30 13F ABBOTT LABS COM 002824100 3,100 -22 -0.70 422 1.69 0.0740
2025-05-09 2025-03-31 13F ABBOTT LABS COM 002824100 3,122 -110 -3.40 414 13.42 0.0795
2025-03-05 2024-12-31 13F ABBOTT LABS COM 002824100 3,232 -284 -8.08 366 -8.75 0.0704
2024-10-16 2024-09-30 13F ABBOTT LABS COM 002824100 3,516 -85 -2.36 401 6.95 0.0768
2024-08-14 2024-06-30 13F ABBOTT LABS COM 002824100 3,601 -4 -0.11 374 -8.56 0.0775
2024-05-03 2024-03-31 13F ABBOTT LABS COM 002824100 3,605 -94 -2.54 410 0.49 0.0847
2024-02-12 2023-12-31 13F ABBOTT LABS COM 002824100 3,699 -261 -6.59 407 6.27 0.0887
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 3,960 32 0.81 384 -10.51 0.0884
2023-08-10 2023-06-30 13F ABBOTT LABS COM 002824100 3,928 -215 -5.19 428 -5.73 0.0935
2023-02-15 2022-12-31 13F ABBOTT LABS COM 002824100 4,143 -97 -2.29 455 10.73 0.1030
2022-11-14 2022-09-30 13F ABBOTT LABS COM 002824100 4,240 -95 -2.19 410 -12.95 0.1018
2022-08-12 2022-06-30 13F ABBOTT LABS COM 002824100 4,335 -224 -4.91 471 -12.78 0.1091
2022-05-10 2022-03-31 13F ABBOTT LABS COM 002824100 4,559 -76 -1.64 540 -17.18 0.1114
2022-02-10 2021-12-31 13F ABBOTT LABS COM 002824100 4,635 -280 -5.70 652 12.22 0.1290
2021-10-08 2021-09-30 13F ABBOTT LABS COM 002824100 4,915 -109 -2.17 581 -0.17 0.1200
2021-08-06 2021-06-30 13F ABBOTT LABS COM 002824100 5,024 -280 -5.28 582 -8.49 0.1226
2021-04-28 2021-03-31 13F ABBOTT LABS COM 002824100 5,304 -290 -5.18 636 4.43 0.1420
2020-11-09 2020-09-30 13F ABBOTT LABS COM 002824100 5,594 -406 -6.77 609 10.93 0.1723
2020-08-03 2020-06-30 13F ABBOTT LABS COM 002824100 6,000 -364 -5.72 549 9.36 0.1701
2020-05-15 2020-03-31 13F ABBOTT LABS COM 002824100 6,364 -739 -10.40 502 -18.64 0.1844
2020-02-13 2019-12-31 13F ABBOTT LABS COM 002824100 7,103 -301 -4.07 617 -0.32 0.1865
2019-11-14 2019-09-30 13F ABBOTT LABS COM 002824100 7,404 410 5.86 619 5.27 0.2009
2019-08-08 2019-06-30 13F ABBOTT LABS COM 002824100 6,994 -503 -6.71 588 -1.84 0.1952
2019-04-29 2019-03-31 13F ABBOTT LABS COM 002824100 7,497 -702 -8.56 599 1.01 0.2060
2019-02-12 2018-12-31 13F ABBOTT LABS COM 002824100 8,199 -735 -8.23 593 -9.47 0.2200
2018-11-14 2018-09-30 13F ABBOTT LABS COM 002824100 8,934 -122 -1.35 655 18.66 0.2127
2018-08-13 2018-06-30 13F ABBOTT LABS COM 002824100 9,056 -370 -3.93 552 -2.30 0.1941
2018-04-16 2018-03-31 13F ABBOTT LABS COM 002824100 9,426 -1,956 -17.19 565 -13.08 0.1957
2018-02-08 2017-12-31 13F ABBOTT LABS COM 002824100 11,382 -1,380 -10.81 650 -4.55 0.2273
2017-10-27 2017-09-30 13F ABBOTT LABS COM 002824100 12,762 -1,374 -9.72 681 -0.87 0.2534
2017-07-27 2017-06-30 13F ABBOTT LABS COM 002824100 14,136 -348 -2.40 687 6.84 0.2593
2017-05-11 2017-03-31 13F ABBOTT LABS COM 002824100 14,484 -636 -4.21 643 10.67 0.2493
2017-02-02 2016-12-31 13F ABBOTT LABS COM 002824100 15,120 25 0.17 581 -8.93 0.2443
2016-11-07 2016-09-30 13F ABBOTT LABS COM 002824100 15,095 127 0.85 638 8.50 0.2753
2016-08-15 2016-06-30 13F ABBOTT LABS COM 002824100 14,968 14,968 588 0.2634
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.